Abstracts
The abstracts of the ECCMID 2008 are displayed on the Wiley-Blackwell website where you can search for abstracts according to subject and author.
Educational Workshops 2008
- EW01: A new threat from an old foe: XDR tuberculosis (ASM)
Presentations - EW02: Pharmacokinetics and pharmacodynamics of anti-infective agents (ISAP)
Presentations - EW03: Interpretive reading of the antibiogram: from MICs and inhibition zones to resistance mechanisms and clinical practice (EUCAST)
Presentations - EW04: Management of patients with B and C viral hepatitis (ESGVH/EASL)
Presentations - EW05: Diagnosis of parasitic infections (EFWISG/ESGCP)
Presentations - EW06: Clostridium difficile – future directions? (ESGCD)
Presentations - EW07: Helicobacter pylori susceptibility testing and treatment failure (EHSG)
Presentations - EW08: Animal models of biofilm infections (ESGB)
Presentations - EW09: New aspects in yeast infections (EFISG)
Presentations
Integrated Symposia 2008
- Positive outcomes in Gram-positive infections (Novartis Pharma AG)
Webcasts - Antifungal therapy: a practical approach to improving outcomes (Schering-Plough)
Webcasts - MRSA: The changing epidemiology of the epidemic (Pfizer)
Webcasts - Management of fungal infection in the ICU setting (Pfizer)
Webcasts - Treating community-acquired pneumonia: is there room for improvement? (Bayer Schering Pharma)
Webcasts - Update in severe communtiy-acquired pneumonia: mortality, mechanisms and medical intervention (Novartis Pharma AG)
Webcasts
EU Information Session - Listen to the insiders: what makes a proposal successful?
All presentations are available for ESCMID Members. Please log in or register.
- Framework Programme 7 (2007-2013) by DG Research, European Commission
Anna Lönnroth (Brussels, BE) - Tips by successful project leaders of FP6 projects
Birgitta Henriques-Normark (Solna, SE) - Tips by successful project leaders of FP6 projects
Kenneth McCullough (Mittelhäusern, CH) - Remarks by an Evaluator of EU research proposals in the field of infection
Ian A. McKay (Leicester, UK)
4th GRACE Postgraduate Course
Defining the burden of antibiotic resistance and LRTI: healthcare indices, mathematical modelling and economic predictors
Convener: Roger Finch, Nottingham, UK
First session
- Antibiotic use in Europe (community vs. hospital)
Herman Goossens, Antwerp, BE - Antibiotic resistance in Europe
Hajo Grundmann, Bilthoven, NL - Healthcare burden of LRTI in Europe in primary care: patient morbidity and mortality
Kerry Hood, Cardiff, UK - Healthcare burden of hospitalised patients with LRTI in Europe: patient morbidity and mortality (Hospital care)
John Macfarlane, Nottingham, UK - News from GRACE: Diagnosis and management of LRTI in Europe: attitudes of doctors and patients
Kerry Hood, Cardiff, UK - News from GRACE: Ongoing studies on aetiology, diagnosis and treatment of LRTI
Paul Little, Southampton, UK
Second session
- Healthcare burden of LRTI in Europe, socioeconomic considerations
Jo Coast, Birmingham, UK - Role and impact of pneumococcal polysaccharide vaccine on respiratory tract infection
Ake Ortqvist, Stockholm, SE - Predicting the impact of paediatric pneumococcal conjugate vaccine on antibiotic resistance and non-vaccine recipients in Europe
Javier Diez Domingo, Valencia, ES - Seasonal influenza - modelling the impact and defining opportunities for its minimisation
Jonathan Van-Tam, London, UK
